DUOT vs JNJ · rev $8.3M vs P/E 17, rev $49.37B
Duos Technologies Group Inc (DUOT) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Duos Technologies Group Inc (DUOT) is a software - application company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DUOT revenue for 2026-06-30 was $8.3M. Net income was $44.4M. DUOT currently screens at market cap $344.8M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DUOT currently screens at market cap $344.8M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DUOT and JNJ stock pages for the full models.
Not investment advice.